Phospholipase C may be involved in norepinephrine-induced cardiac hypertrophy

Biochemical and Biophysical Research Communications

Volumn 320, Issue 3, 2004, Pages 1015-1019

  Singal, Tushi ^a   Dhalla, Naranjan S ^a   Tappia, Paramjit S ^a  

^a NONE

Author keywords

Adrenoceptors; Adult cardiomyocytes; Norepinephrine; Phospholipase C; Prazosin; Protein synthesis

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ATRIAL NATRIURETIC FACTOR; DIACYLGLYCEROL; NORADRENALIN; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; PRAZOSIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CARDIOMEGALY; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART VENTRICLES; MALE; MYOCYTES, CARDIAC; NOREPINEPHRINE; PHOSPHOLIPASE C; RATS; RATS, SPRAGUE-DAWLEY;

EID: 3042798884     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.06.052     Document Type: Article

References (31)

1. Gardner D.G., Deschepper C.F., Ganong W.F., Hane S., Fiddes J., Baxter J.D., Lewicki J. Extra-atrial expression of the gene for atrial natriuretic factor. Proc. Natl. Acad. Sci. USA. 83:1986;6697-6701
2. Chien K.R., Knowlton K.U., Zhu h., Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J. 5:1991;3037-3046
3. Hefti M.A., Harder B.A., Eppenberger H.M., Schaub M.C. Signaling pathways in cardiac myocyte hypertrophy. J. Mol. Cell. Cardiol. 29:1997;2873-2892
4. Sugden P.H. Signaling in myocardial hypertrophy: life after calcineurin. Circ. Res. 84:1999;633-646
5. 1b -adrenergic receptor subtypes reveal coupling to different signaling pathways and physiological responses in rat cardiac myocytes J. Biol. Chem. 275:2000;2087-2097
6. Taigen T., De Windt L.J., Lim H.W., Molkentin J.D. Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. Proc. Natl. Acad. Sci. USA. 97:2000;1196-1201
7. Omura T., Yoshiyama M., Yoshida K., Nakamura Y., Kim S., Iwao H., Takeuchi K., Yoshikawa J. Dominant negative mutant of c-Jun inhibits cardiomyocyte hypertrophy induced by endothelin-1 and phenylephrine. Hypertension. 39:2002;81-86
8. Touyz R.M., Berry C. Recent advances in angiotensin II signaling. Braz. J. Med. Biol. Res. 35:2002;1001-1015
9. Kelso E.J., McDermott B.J., Silke B., Spiers J.P. Endothelin (A) receptor subtype mediates endothelin-induced contractility in left ventricular cardiomyocytes isolated from rabbit myocardium. J. Pharmacol. Exp. Ther. 294:2000;1047-1052
10. 1 -Adrenoceptor subtypes Eur. J. Pharmacol. 375:1999;261-276
11. Gilbert J.C., Shirayama T., Pappano A.J. Inositol triphosphate promotes Na-Ca exchange current by releasing calcium from sarcoplasmic reticulum in cardiac myocytes. Circ. Res. 69:1991;1632-1639
12. 3 binding site in rat heart sarcoplasmic reticulum. J. Mol. Cell. Cardiol. 26:1994;341-349
13. Kijimi Y., Fleischer S. Two types of inositol triphosphate binding in cardiac microsomes. Biochem. Biophys. Res. Commun. 189:1992;728-735
14. Kijimi Y., Saito A., Jetton T.L., Magnusson M.A., Fleischer S. Different intracellular localization of inositol 1, 4, 5-triphosphate and ryanodine receptors in cardiomyocytes. J. Biol. Chem. 268:1993;3499-3506
15. Puceat M., Vassort G. Signalling by protein kinase C isoforms in the heart. Mol. Cell. Biochem. 157:1996;65-72
16. q, PLC β1, and PKC Cardiovasc. Res. 44:1999;5-9
17. Munakata M., Stamm C., Friehs I., Zurakowski D., Cowan D.B., Cao-Danh H., McGowan F.X. Jr., del Nido P.J. Protective effects of protein kinase C during myocardial ischemia require activation of phosphatidyl-inositol specific phospholipase C. Ann. Thorac. Surg. 73:2002;1236-1245
18. Tappia P.S., Yu C.H., Di Nardo P., Pasricha A.K., Dhalla N.S., Panagia V. Depressed responsiveness of phospholipase C isoenzymes to phosphatidic acid in congestive heart failure. J. Mol. Cell. Cardiol. 33:2001;431-440
19. M.R. Dent, N.S. Dhalla, P.S. Tappia, Phospholipase C gene expression, protein content and activities in cardiac hypertrophy and heart failure due to volume overload, Am. J. Physiol. (2004) in press
20. Xu Y.J., Yau L., Yu L.P., Elimban V., Zahradka P., Dhalla N.S. Stimulation of protein synthesis by phosphatidic acid in rat cardiomyocytes. Biochem. Pharmacol. 52:1996;1735-1740
21. Liu J.C., Chan P., Chen J.J., Lee H.M., Lee W.S., Shih N.L., Chen Y.L., Hong H.J., Cheng T.H. The inhibitory effect of trilinolein on norepinephrine-induced β-myosin heavy chain promoter activity, reactive oxygen species generation, and extracellular signal-regulated kinase phosphorylation in neonatal rat cardiomyocytes. J. Biomed. Sci. 11:2004;1-8
22. 1 -adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy J. Biol. Chem. 272:1997;14057-14061
23. Eskildsen-Helmond Y.E., Bezstarosti K., Dekkers D.H., van Heugten H.A., Lamers J.M. Cross-talk between receptor-mediated phospholipase C-β and D via protein kinase C as intracellular signal possibly leading to hypertrophy in serum-free cultured cardiomyocytes. J. Mol. Cell. Cardiol. 29:1997;2545-2559
24. 1 -Adrenergic receptor agonists stimulate ribosome formation in hearts from enalapril-treated piglets J. Mol. Cell. Cardiol. 25:1993;395-406
25. Hannan R.D., Stennard F.A., West A.K. Localization of c-myc protooncogene expression in the rat heart in vivo and in isolated, perfused heart following treatment with norepinephrine. Biochim. Biophys. Acta. 1217:1994;281-290
26. Lahteenmaki T.A., Sievi E., Vapaatalo H. Antihypertensive drugs reduce noradrenaline-induced hypertrophy of cultured myocardial cells. J. Pharm. Pharmacol. 48:1996;323-326
27. Milano C.A., Dolber P.C., Rockman H.A., Bond R.A., Venable M.E., Allen L.F., Lefkowitz R.J. Myocardial expression of a constitutively active 1β-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc. Natl. Acad. Sci. USA. 91:1994;10109-10113
28. 1 -adrenoceptor subtype- and protein kinase C isoform-dependence of norepinephrine's actions in cardiomyocytes J. Mol. Cell. Cardiol. 32:2000;1193-1209
29. 1A -adrenoceptors Naunyn Schmiedebergs Arch. Pharmacol. 364:2001;444-453
30. Yamazaki T., Komuro I., Zou Y., Kudoh S., Mizuno T., Hiroi Y., Shiojima I., Takano H., Kinugawa K., Kohmoto O., Takahashi T., Yazaki Y. Protein kinase A and protein kinase C synergistically activate the Raf-1 kinase/mitogen- activated protein kinase cascade in neonatal rat cardiomyocytes. J. Mol. Cell. Cardiol. 29:1997;2491-2501
31. Yamazaki T., Yazaki Y. Molecular basis of cardiac hypertrophy. Z. Kardiol. 89:2000;1-6